NDC-1308 A NOVEL THERAPEUTIC FOR COVID-19

We need both vaccines and therapeutics as not everyone will be immunized effectively against SARS-CoV-2 / COVID-19 The search for a SARS-CoV-2 vaccine continues to be of high priority. However, there are several aspects of SARS-CoV-2 and other viruses, such as the...

NDC-1308 (MC1) Therapeutic for Seasonal Viral Influenza

Within the US alone, there are over 200,000 hospitalizations annually from seasonal viral influenza. Patients requiring mechanical ventilation have a high mortality rate of 20% or over 40,000 people annually.The World Health Organization (WHO) estimates that influenza...

Differences Between NDC-1308 (MC1) and Dexamethasone

The differences between NDC-1308 (MC1) and Dexamethasone proposed Mechanism of Action (MOA) support NDC-1308 (MC1) may have increased efficacy compared to Dexamethasone in all COVID-19 patient groups. By addressing the early signs of lung inflammation in COVID-19...

Macrophage Inflammation In The Lungs

WHAT IS A MACROPHAGE? A macrophage is a type of white blood cell called a phagocyte. It is the first line of defense that cleans the body of bacteria and viruses called antigens. When a macrophage locates an antigen, it engulfs and destroys it. Upon being presented...